Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries

作者：Hongmei Zeng, Wanqing Chen, Rongshou Zheng, Siwei Zhang, John S. Ji, Xiaonong Zou, Changfa Xia, Kexin Sun, Zhixun Yang, He Li, Ning Wang, Renqiang Han, Shuzheng Liu, Huizhang Li, Huijuan Mu, Yutong He, Yanjun Xu, Zhentao Fu, Yan Zhou, Jie Jiang, Yanlei Yang, Jianguo Chen, Kuangrong Wei, Dongmei Fan, Jian Wang, F X Fu, Deli Zhao, Guohui Song, Jianshun Chen, Chunxiao Jiang, Xin Zhou, Xiaoping Gu, Feng Jin, Qilong Li, Yanhua Li, T H Wu, Chunhua Yan, Jianmei Dong, Zhaolai Hua, Peter D. Baade, Freddie Bray, Ahmedin Jemal, Xue Qin Yu, Jie He · 发表于：The Lancet Global Health · 年份：2018 · DOI：10.1016/s2214-109x(18)30127-x · 被引用次数：1611 · 研究领域：Global Cancer Incidence and Screening、Multiple and Secondary Primary Cancers、Economic and Financial Impacts of Cancer

BACKGROUND: From 2003 to 2005, standardised 5-year cancer survival in China was much lower than in developed countries and varied substantially by geographical area. Monitoring population-level cancer survival is crucial to the understanding of the overall effectiveness of cancer care. We therefore aimed to investigate survival statistics for people with cancer in China between 2003 and 2015. METHODS: We used population-based data from 17 cancer registries in China. Data for the study population was submitted by the end of July 31, 2016, with follow-up data on vital status obtained on Dec 31, 2015. We used anonymised, individual cancer registration records of patients (aged 0-99 years) diagnosed with primary, invasive cancers from 2003 to 2013. Patients eligible for inclusion had data for demographic characteristics, date of diagnosis, anatomical site, morphology, behaviour code, vital status, and last date of contact. We analysed 5-year relative survival by sex, age, and geographical area, for all cancers combined and 26 different cancer types, between 2003 and 2015. We stratified survival estimates by calendar period (2003-05, 2006-08, 2009-11, and 2012-15). FINDINGS: There were 678 842 records of patients with invasive cancer who were diagnosed between 2003 and 2013. Of these records, 659 732 (97·2%) were eligible for inclusion in the final analyses. From 2003-05 to 2012-15, age-standardised 5-year relative survival increased substantially for all cancers combined, for bot...